loadpatents
name:-2.1036579608917
name:-0.51797008514404
name:-0.90460896492004
Izrael; Michal Patent Filings

Izrael; Michal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Izrael; Michal.The latest application filed is for "directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)".

Company Profile
4.7.14
  • Izrael; Michal - Rechovot IL
  • Izrael; Michal - Rehovot IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
Grant 11,406,670 - Revel , et al. August 9, 2
2022-08-09
Directed Differentiation Of Astrocytes From Human Pluripotent Stem Cells For Use In Drug Screening And The Treatment Of Amyotrophic Lateral Sclerosis (als)
App 20210054334 - Izrael; Michal ;   et al.
2021-02-25
Method Of Identifying Agents That Affect Maturation, Survival And Myelination
App 20200003757 - Revel; Michel ;   et al.
2020-01-02
Methods Of Generating Glial And Neuronal Cells And Use Of Same For The Treatment Of Medical Conditions Of The Cns
App 20190175658 - Revel; Michel ;   et al.
2019-06-13
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
Grant 10,258,651 - Revel , et al.
2019-04-16
Directed Differentiation Of Astrocytes From Human Pluripotent Stem Cells For Use In Drug Screening And The Treatment Of Amyotrophic Laterial Sclerosis (als)
App 20180230427 - Izrael; Michal ;   et al.
2018-08-16
Methods Of Generating Glial And Neuronal Cells And Use Of Same For The Treatment Of Medical Conditions Of The Cns
App 20170362570 - Revel; Michel ;   et al.
2017-12-21
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
Grant 9,631,175 - Revel , et al. April 25, 2
2017-04-25
Methods Of Inducing Myelination And Maturation Of Oligodendrocytes
App 20170095512 - Izrael; Michal ;   et al.
2017-04-06
Directed Differentiation Of Astrocytes From Human Pluripotent Stem Cells For Use In Drug Screening And The Treatment Of Amyotrophic Laterial Sclerosis (als)
App 20160237404 - IZRAEL; Michal ;   et al.
2016-08-18
Insulin producing cells derived from pluripotent stem cells
Grant 9,404,087 - Revel , et al. August 2, 2
2016-08-02
Methods Of Generating Glial And Neuronal Cells And Use Of Same For The Treatment Of Medical Conditions Of The Cns
App 20140322179 - Revel; Michel ;   et al.
2014-10-30
Method Of Identifying Agents That Affect Maturation, Survival And Myelination
App 20140296107 - Revel; Michel ;   et al.
2014-10-02
Methods of generating mature oligodendrocytes
Grant 8,809,052 - Revel , et al. August 19, 2
2014-08-19
Insulin Producing Cells Derived From Pluripotent Stem Cells
App 20130273013 - Revel; Michel ;   et al.
2013-10-17
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
App 20100003751 - Revel; Michel ;   et al.
2010-01-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed